trial

Oxytocin and CBSST for People With Schizophrenia

NCTId NCT01752712
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 83 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2016-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
83 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2014-01
Primary completion
2016-08
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
CBSST + Oxytocin

Sponsors

University of Maryland, Baltimore CountyLead Sponsor
University of California Riverside at C.I. Trials, Inc.-Inland EmpireCollaborator

Investigators

1
Robert W Buchanan, MDPrincipal Investigator

Sites

2 total
San Diego, United StatesBaltimore, United States

Facts & assertions

4 sourced
Enrollment
83
Phase
NA
Primary Completion Date
2016-08
Status
COMPLETED
relationships
The graph out of here
drug
CBSST + Oxytocin
drug
lead_sponsor
University of Maryland, Baltimore County
company
collaborator
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
Schizophrenia
indication
investigator
Robert W Buchanan, MD
person